A Multicentre, Single-arm, Open-label Safety Study of Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Dexamethasone
Related studies linked through entity extraction aliases.
Dexamethasone and Chemotherapy With or Without Plasma Exchange in Patients With Newly Diagnosed Multiple Myeloma and Acute Kidney Failure
- Status
- COMPLETED
- Phase
- PHASE3
Phase I Study of Perifosine + Lenalidomide and Dexamethasone for Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Pulses of Vincristine and Dexamethasone in BFM Protocols for Children With Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE4
Floxuridine and Dexamethasone as a Hepatic Arterial Infusion and Bevacizumab in Treating Patients With Primary Liver Cancer That Cannot be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Stage II or III Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Palonosetron in Sarcoma Patients Receiving Chemotherapy With Adriamycin and Ifosfamide (AI)
- Status
- COMPLETED
- Phase
- NA
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
Phase 2 Neoadjuvant Doxorubicin and Cyclophosphamide -> Docetaxel With Lapatinib in Stage II/III Her2Neu+ Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Dexamethasone for Paediatric Adeno-tonsillectomy - A Dose-finding Study
- Status
- TERMINATED
- Phase
- PHASE4
Dexamethasone and Supportive Care With or Without Whole-Brain Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer That Has Spread to the Brain and Cannot Be Removed By Surgery
- Status
- COMPLETED
- Phase
- PHASE3
Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma
- Status
- COMPLETED
- Phase
- PHASE1
An Efficacy and Safety Study of Siltuximab in Participants With Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
A Study of the Safety and Efficacy of CNTO 328 and Bortezomib to Bortezomib Alone in Patients With Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Safety & Efficacy Study of Perifosine + Bortezomib +/- Dexamethasone for Multiple Myeloma Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
05-001: Treatment of Acute Lymphoblastic Leukemia in Children
- Status
- COMPLETED
- Phase
- PHASE3
Combination Chemotherapy and Dasatinib in Treating Participants With Philadelphia Positive or BCR-ABL Positive Acute Lymphoblastic Leukemia.
- Status
- COMPLETED
- Phase
- PHASE2
Bortezomib and Dexamethasone in Treating Patients With Multiple Myeloma That Has Relapsed or Has Not Responded to Treatment
- Status
- UNKNOWN
- Phase
- PHASE2
Phase II Trial of Aprepitant & Palonosetron for CINV Prevention w FOLFOX
- Status
- COMPLETED
- Phase
- PHASE2
Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE3